LASA SUPERGENERICS
Back to Income Statement
|
LASA SUPERGENERICS Last 5 Year Earnings Per Share (EPS) History
[Standalone]
| Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
|---|---|---|---|---|---|
| Adjusted EPS | ₹-4.34 | ₹-7.71 | ₹-1.06 | ₹5.60 | ₹0.89 |
What is the latest Earnings Per Share (EPS) of LASA SUPERGENERICS ?
| Year | Earnings Per Share (EPS) |
|---|---|
| Mar2024 | ₹-4.34 |
| Mar2023 | ₹-7.71 |
| Mar2022 | ₹-1.06 |
| Mar2021 | ₹5.60 |
| Mar2020 | ₹0.89 |
How is Earnings Per Share (EPS) of LASA SUPERGENERICS Trending?
| Years | Earnings Per Share (EPS) | % Change | |
|---|---|---|---|
| Mar2024 | ₹-4.34 | Negative | |
| Mar2023 | ₹-7.71 | Negative | |
| Mar2022 | ₹-1.06 | Negative | |
| Mar2021 | ₹5.60 | 529.21 | |
| Mar2020 | ₹0.89 | - | |
Compare Earnings Per Share (EPS) of peers of LASA SUPERGENERICS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LASA SUPERGENERICS | ₹55.0 Cr | -4.5% | -2.4% | -61.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹415,529.0 Cr | 2.7% | 3.7% | -6.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹173,067.0 Cr | -5.3% | 0.6% | 10% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹129,376.0 Cr | 7.5% | 8.1% | 19.2% | Stock Analytics | |
| CIPLA | ₹122,773.0 Cr | 1.3% | -2.7% | -5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,595.0 Cr | 2% | -2.8% | -7% | Stock Analytics | |
LASA SUPERGENERICS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LASA SUPERGENERICS | -4.5% |
-2.4% |
-61.6% |
| SENSEX | 1.2% |
2.8% |
6.3% |
You may also like the below Video Courses